67457-257 : Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution


NDC67457-257
Labeler: Mylan Institutional LLC
Product Type: Human Prescription Drug
Drug Name:  Cosyntropin
Dosage Form: Intramuscular; Intravenous Injection, Powder, for Solution
Application #: ANDA090574
Rev. Date: 


NDC Package Codes:

  • 67457-257-02: 10 VIAL IN 1 CARTON (67457‑257‑02) > 1 ML IN 1 VIAL (67457‑257‑00)

Active Ingredients:

  • Cosyntropin

Dosage Strength:

  • .25 mg/mL

Pharmaceutical Classes:

  • Adrenocorticotropic Hormone [Chemical/Ingredient]
  • Adrenocorticotropic Hormone [EPC]

Related Products:

Based on records with the same trade name.
  • 67457-227 Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution by Mylan Institutional LLC
  • 0781-3052 Cosyntropin .25 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3440 Cosyntropin .25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 10139-905 Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Generamedix

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67457-257 QR Code

< Prev: 67457-256Next: 67457-259 >

Related Discussions:

Cosyntropin
I can see that the Amphastar product is the one mostly usded. Can anyone tell me what is the difference between the Sand...
Cosyntropin
I have been invited to participate in a study using this drug. I was unable to access information about this drug on the...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA